isophosphamide mustard has been researched along with Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Constantinidou, A; van der Graaf, WTA | 1 |
| Brennan, C; Hartley, JM; Nicholson, PW; Singer, JM; Souhami, RL | 1 |
1 trial(s) available for isophosphamide mustard and Sarcoma
| Article | Year |
|---|---|
The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study.
Topics: Adult; Aged; Antineoplastic Agents; Biotransformation; Cross-Over Studies; Cyclophosphamide; Dexamethasone; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Phosphoramide Mustards; Sarcoma; Sarcoma, Ewing | 1998 |
1 other study(ies) available for isophosphamide mustard and Sarcoma
| Article | Year |
|---|---|
The fate of new fosfamides in phase III studies in advanced soft tissue sarcoma.
Topics: Antineoplastic Agents, Alkylating; Clinical Trials, Phase III as Topic; Evidence-Based Medicine; Humans; Neoplasm Staging; Nitroimidazoles; Phosphoramide Mustards; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Treatment Outcome | 2017 |